Industries > Pharma > Genome Editing Technologies Market Report 2024-2034
Back to Pharma Reports
Genome Editing Technologies Market Report 2024-2034

Genome Editing Technologies Market Report 2024-2034

Forecasts by Technology (CRISPR, TALEN, ZFN, Meganucleases, Others), by Application (Genetic Engineering (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others), Drug Discovery & Development, Diagnostic Applications)), by End-users (Biotechnology Companies, Pharmaceutical Companies, Academic & Government Research Institutes, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 31 May 2024
PAGES: 311
PRODUCT CODE: PHA1339
SUBMARKET: Next Generation Technologies

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1339 Categories: , Tag:

The Genome Editing Technologies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Emerging Economies Projected to Boost Industry Growth

Emerging economies such as China, India, South Africa, Mexico, Singapore, Brazil, Russia, South Korea, Indonesia, and Turkey are becoming significant players in the genome editing technologies industry. China, in particular, has made substantial investments and advancements in genome editing, propelling the nation to the forefront of global research and application. Institutions like BGI Genomics and Huada Genomics Institute are leading efforts in CRISPR-Cas9 technology, achieving breakthroughs in human health and significant strides in agriculture. These advancements address critical issues such as food security and sustainability, presenting a significant long-term growth opportunity for life science research in the Chinese market. The country’s spending on R&D surpassed US$458.5 billion in 2023, an 8.1% increase from the previous year, reflecting rising health demands from an aging population.

India and Brazil are also making notable progress in genome editing technologies. India, with its vast population and burgeoning biotechnology sector, has companies like Rasi Seeds and MedGenome spearheading research in crop improvement and personalized medicine. This focus on healthcare and agriculture highlights India’s commitment to leveraging genome editing for societal benefit. Similarly, Brazil is recognizing the potential of genome editing to address its healthcare and agricultural challenges. Institutions like Embrapa and companies like Recepta Biopharma are actively developing novel therapies and crop varieties tailored to the country’s needs, driving advancements in precision medicine and agricultural productivity. These efforts position Brazil as a key player in the global genome editing landscape.

Off-target Effects of CRISPR Technology Likely to Challenge Industry Growth

One major limitation of gene editing technology is the off-target effects of CRISPR-Cas9. While CRISPR can target specific genes with high precision, it can also cause unintended alterations at other sites in the genome. These off-target effects present risks and challenges, making it essential to ensure precise targeting to avoid unwanted changes and adverse outcomes. Researchers are improving CRISPR procedures to increase specificity and reduce off-target effects through advancements in guide RNA design, high-fidelity Cas9 variants, and bioinformatics tools.

Off-target effects pose significant concerns for the safety and efficacy of genome editing treatments, impeding market demand. Unintended genetic changes can lead to harmful side effects, potentially introducing new mutations or exacerbating existing conditions. Regulatory scrutiny and public perception further hinder market growth. Regulators, like the FDA, require rigorous testing to ensure safety, which is time-consuming and costly. Public skepticism about the risks of off-target effects can also deter patients from seeking genome editing treatments. To address these challenges, researchers are developing new tools and techniques to enhance CRISPR precision and mitigate off-target effects, aiming to boost confidence and demand in the market.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the genome editing technologies market evolving?
  • What is driving and restraining the genome editing technologies market?
  • How will each genome editing technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each genome editing technologies submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading genome editing technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the genome editing technologies projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of genome editing technologies projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the genome editing technologies market?
  • Where is the genome editing technologies market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the genome editing technologies market today, and over the next 10 years:

  • Our 311-page report provides 127 tables and 182 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the genome editing technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising genome editing technologies prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Technology

  • CRISPR
  • TALEN
  • ZFN
  • Meganucleases
  • Others

Application

  • Genetic Engineering
    – Cell Line Engineering
    – Animal Genetic Engineering
    – Plant Genetic Engineering
    – Others
  • Drug Discovery & Development
  • Diagnostic Applications

End-users

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Other End-users

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

Genome Editing Technologies Market Report 2024-2034
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Genome Editing Technologies Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

  • Agilent Technologies
  • Caribou Biosciences, Inc.
  • Cellectis
  • Cibus Inc.
  • CRISPR Therapeutics
  • Danaher Corporation
  • Editas Medicine
  • GenScript
  • Intellia Therapeutics Inc.
  • Lonza
  • Merck KGaA
  • Precision Biosciences
  • Recombinetics
  • Revvity
  • Sangamo Therapeutics
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

Overall world revenue for Genome Editing Technologies Market, 2024 to 2034 in terms of value the market will surpass US$6,300.0 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Genome Editing Technologies Market, 2024 to 2034 report help you?

In summary, our 310+ page report provides you with the following knowledge:

  • Revenue forecasts to 2034 for Genome Editing Technologies Market, 2024 to 2034, with forecasts for technology, application, and end-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 22 key national markets – See forecasts for the Genome Editing Technologies Market, 2024 to 2034 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also includes forecast for the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 18 of the major companies involved in the Genome Editing Technologies Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Genome Editing Technologies Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Genome Editing Technologies Market Report 2024-2034: Forecasts by Technology (CRISPR, TALEN, ZFN, Meganucleases, Others), by Application (Genetic Engineering (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others), Drug Discovery & Development, Diagnostic Applications)), by End-users (Biotechnology Companies, Pharmaceutical Companies, Academic & Government Research Institutes, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Genome Editing Technologies Market Report 2024-2034

    Related reports

    Download sample pages

    Complete the form below to download your free sample pages for Genome Editing Technologies Market Report 2024-2034

      • Don’t Miss Out!

      Latest Pharma news

      Retinal Gene Therapy Market

      The global Retinal Gene Therapy market is projected to grow at a CAGR of 9.6% by 2034

      26 July 2024

      READ
      HIV Drugs and Injectables Market

      The global HIV Drugs & Injectables market is projected to grow at a CAGR of 4.6 % by 2034

      24 July 2024

      READ
      Digital Twin Technology in Pharmaceutical Manufacturing Market

      The global Digital Twin Technology in Pharmaceutical Manufacturing market is projected to grow at a CAGR of 31.3% by 2034

      23 July 2024

      READ
      Specialty Pharma Market

      The global Specialty Pharma market is projected to grow at a CAGR of 7.5% by 2034

      22 July 2024

      READ